Tate, M., Illingworth, C., MacGregor, G., Cunningham, L., Divers, L., McCartney, E., Paterson, L., Kelly, C., Shaw, A., Perkins, J., Silva, V., Holland, P., Dalton, C., Carmichael, S., Douglas, E., Surtees, P., Scott, J., Berry, C., Vattipally, S., da Silva Filipe, A., Tong, L., Gunson, R., co-investigators, G., McInnes, I., Jones, R., Thomson, E. & Blyth, K. 2025, 'Clinical effectiveness, safety and viral mutagenicity of oral favipiravir for COVID-19: results from a community-based, open-label, randomised, phase III trial', Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00054-25